Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

InnoCan Pharma

Explore full profile

Developing over-the-counter Cannabinoid-based drugs for psoriasis and muscle and joint pains

Tel Aviv-Yafo, IsraelFounded 2017Biotech & Life Sciences
Valuation $6.3M Market cap · 2026
Revenue $27M Latest reported FY

About InnoCan Pharma

Innocan Pharma is a specialty pharmaceutical company focused on developing innovative products that utilize the unique properties of cannabinoids combined with advanced delivery systems. The company operates in the pharmaceutical and wellness markets, targeting both consumers and healthcare providers. Innocan Pharma's business model revolves around the research, development, and commercialization of cannabinoid-based products, including topical treatments, sprays, and injectables. Revenue is generated through product sales, partnerships, and licensing agreements. The company aims to address various health and wellness needs, offering solutions such as CBD sprays, luxury face oils, and premium sleeping masks. Innocan Pharma leverages its expertise in marketing, sales distribution, and strategic development to expand its market presence and drive growth. Key clients include individuals seeking wellness products and healthcare providers looking for advanced treatment options. The company is led by experienced executives with a strong background in the pharmaceutical industry, ensuring robust business development and operational strategies.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2017
Headquarters
Tel Aviv-Yafo, Israel
Listing
IPO 2019
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • PipelBiz
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇮🇱 Israel80%
🇺🇸 United States10%
🇨🇦 Canada10%
3 countries shown
Web traffic by country
630 monthly visits
across markets
🇮🇱 Israel79.4%
🇺🇸 United States31.7%
Top 2 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about InnoCan Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See InnoCan Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.